Home > Insider Trading > Filing (0000904454-19-000600)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1427570	Obalon Therapeutics Inc	OBLN	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1013425	I Jesse Treu	C/O Domain Associates, Llc 202 Carnegie Center, Suite 104 Princeton NJ 08540	No	No	Yes	No
1024000	C James Blair	C/O Domain Associates, Llc 202 Carnegie Center, Suite 104 Princeton NJ 08540	No	No	Yes	No
1196863	Nicole Vitullo	C/O Domain Associates, Llc 202 Carnegie Center, Suite 104 Princeton NJ 08540	No	No	Yes	No
1207786	H Brian Dovey	C/O Domain Associates, Llc 202 Carnegie Center, Suite 104 Princeton NJ 08540	No	No	Yes	No
1354718	K Brian Halak	C/O Domain Associates, Llc 202 Carnegie Center, Suite 104 Princeton NJ 08540	No	No	Yes	No
1374150	P L Vii Parters Domain	C/O Domain Associates, Llc 202 Carnegie Center, Suite 104 Princeton NJ 08540	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-08-06	250,000	$4.00	813,433	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants to Purchase Common Stock	Acquisiton	2019-08-06	187,500	$4.00	187,500	$4.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
187,500	2019-08-06	2024-08-06	No	4	P	Direct

Footnotes

The reported securities were purchased as Units, each Unit consisting of one share of Common Stock and a Warrant to purchase 0.75 of one share of Common Stock, at a purchase price of $4.00 per Unit.
The reported ownership reflects the one-for-ten reverse split of the Common Stock effected on July 24, 2019.
The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
As managing members of One Palmer Square Associates VII, LLC, which is also the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own 4,957 shares of Common Stock held by DP VII Associates, L.P.